Literature DB >> 9842892

TNF-induced enterocyte apoptosis in mice is mediated by the TNF receptor 1 and does not require p53.

P F Piguet1, C Vesin, J Guo, Y Donati, C Barazzone.   

Abstract

Injection of recombinant mouse TNF into mice is known to induce a shrinkage of the duodenal villi, which becomes evident 30-90 min later and is associated with a detachment of enterocytes in the lumen. These cells can be collected by lavage and are all apoptotic, i.e. hypodiploid as seen by flow cytometric analysis. Thus the count of detached cells was used as an evaluation of the TNF-induced cell loss and apoptosis in the mucosa. TNF injection induced a cell loss of similar magnitude in wild-type (+/+) or in mice lacking the TNF receptor (TNFR)2 (p75, TNFR2-/-), while mice lacking the TNFR1 (p55, TNFR1-/-) were completely resistant to this effect. TNF increased the expression of p53 tumor suppressor gene in the enterocytes from the crypts but not from the villi, as seen by Western blots and histochemistry. TNF increased the expression of p53 in both TNFR2-/- and TNFR1-/- mice. Furthermore, enterocyte cell loss was not attenuated in p53-/- mice. The results indicate that TNF, acting on its receptor 1, induces an apoptotic detachment of the enterocytes from the tip of the villi (i.e. the old enterocytes), while in the enterocytes from the crypts (the young enterocytes) TNF increases, via either TNFR1 or TNFR2, the expression of p53, without inducing apoptosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9842892     DOI: 10.1002/(SICI)1521-4141(199811)28:11<3499::AID-IMMU3499>3.0.CO;2-Q

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  42 in total

Review 1.  Tumour necrosis factor in mouse models of chronic intestinal inflammation.

Authors:  Christoph Mueller
Journal:  Immunology       Date:  2002-01       Impact factor: 7.397

2.  The specific JNK inhibitor SP600125 targets tumour necrosis factor-alpha production and epithelial cell apoptosis in acute murine colitis.

Authors:  Kiran Assi; Rex Pillai; Antonio Gómez-Muñoz; David Owen; Baljinder Salh
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

3.  Moxibustion inhibits apoptosis and tumor necrosis factor-alpha/tumor necrosis factor receptor 1 in the colonic epithelium of Crohn's disease model rats.

Authors:  Chun-Hui Bao; Lu-Yi Wu; Huan-Gan Wu; Yin Shi; Hui-Rong Liu; Rong Zhang; Li-Qing Yu; Jin-Hai Wang
Journal:  Dig Dis Sci       Date:  2012-04-25       Impact factor: 3.199

4.  Tumor necrosis factor-alpha induces apoptosis of enterocytes in mice with fulminant hepatic failure.

Authors:  Hong-Li Song; Sa Lu; Pei Liu
Journal:  World J Gastroenterol       Date:  2005-06-28       Impact factor: 5.742

5.  Transmembrane tumor necrosis factor alpha is required for enteropathy and is sufficient to promote parasite expulsion in gastrointestinal helminth infection.

Authors:  M X Ierna; H E Scales; C Mueller; C E Lawrence
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

6.  Lactobacillus reuteri maintains intestinal epithelial regeneration and repairs damaged intestinal mucosa.

Authors:  Haiqin Wu; Shuang Xie; Jinfeng Miao; Yuchen Li; Zhihua Wang; Minjuan Wang; Qinghua Yu
Journal:  Gut Microbes       Date:  2020-03-05

7.  Atg14 protects the intestinal epithelium from TNF-triggered villus atrophy.

Authors:  Haerin Jung; J Steven Leal-Ekman; Qiuhe Lu; Thaddeus S Stappenbeck
Journal:  Autophagy       Date:  2019-04-03       Impact factor: 16.016

8.  Attenuation of TNF-driven murine ileitis by intestinal expression of the viral immunomodulator CrmD.

Authors:  A Viejo-Borbolla; A P Martin; L R Muniz; L Shang; F Marchesi; N Thirunarayanan; N Harpaz; R A Garcia; M Apostolaki; G C Furtado; L Mayer; G Kollias; A Alcami; S A Lira
Journal:  Mucosal Immunol       Date:  2010-07-21       Impact factor: 7.313

9.  Safe TNF-based antitumor therapy following p55TNFR reduction in intestinal epithelium.

Authors:  Filip Van Hauwermeiren; Marietta Armaka; Niki Karagianni; Ksanthi Kranidioti; Roosmarijn E Vandenbroucke; Sonja Loges; Maarten Van Roy; Jan Staelens; Leen Puimège; Ajay Palagani; Wim Vanden Berghe; Panayiotis Victoratos; Peter Carmeliet; Claude Libert; George Kollias
Journal:  J Clin Invest       Date:  2013-05-15       Impact factor: 14.808

10.  Type I interferon drives tumor necrosis factor-induced lethal shock.

Authors:  Liesbeth Huys; Filip Van Hauwermeiren; Lien Dejager; Eline Dejonckheere; Stefan Lienenklaus; Siegfried Weiss; Georges Leclercq; Claude Libert
Journal:  J Exp Med       Date:  2009-08-17       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.